Prosecution Insights
Last updated: October 02, 2026

Examiner: YOUNG, BRIAN ELLIS

Tech Center 1600 • Art Units: 1672 1681 1682 1683 1684

This examiner grants 66% of resolved cases

Analysis

Brian Ellis Young is an examiner in Tech Center 1600, Art Unit 1672. He has 38 resolved cases and an allowance rate of 65.8 percent. The median time to reach an allowance is 1389 days. The 65.8 percent allowance rate indicates a better than average chance of securing a patent grant in this art unit.

The interview lift is 24.8 percent. This indicates that interviews are a useful tool for applicants, providing a significant increase over the 65.8 percent baseline. Given the long median pendency of 1389 days, proactive engagement through interviews may be a key strategy for navigating this examiner's process. The 24.8 percent lift suggests that the examiner is responsive to verbal discussion. With 38 resolved cases, the data shows a clear benefit to direct communication. Practitioners should prepare for a prosecution cycle of 1389 days and use interviews to resolve outstanding issues. This approach may help move applications toward a grant more effectively. The 24.8 percent lift is a strong reason to engage.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

65.8%
Allow Rate
+5.8% vs TC avg
68
Total Applications
+24.8%
Interview Lift
1389
Avg Prosecution Days
Based on 38 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
14.7%
§102 Novelty
37.5%
§103 Obviousness
26.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18227786 METHODS FOR AMPLIFICATION OF CELL-FREE DNA USING LIGATED ADAPTORS AND UNIVERSAL AND INNER TARGET-SPECIFIC PRIMERS FOR MULTIPLEXED NESTED PCR Non-Final OA Natera, Inc.
19417711 METHODS FOR SPATIAL ANALYSIS USING RNA-TEMPLATED LIGATION Final Rejection 10x Genomics, Inc.
18455201 METHODS OF ENZYMATICALLY REPAIRING CLEAVED RNAS AND DETECTING THEREOF Non-Final OA THE JOHNS HOPKINS UNIVERSITY
17062375 High-throughput method to screen cognate T cell and epitope reactivities in primary human cells Final Rejection Regeneron Pharmaceuticals, Inc.
17626598 METHODS AND COMPOSITIONS FOR SCALABLE POOLED RNA SCREENS WITH SINGLE CELL CHROMATIN ACCESSIBILITY PROFILING Final Rejection New York University
17326475 METHODS FOR TARGETED NUCLEIC ACID LIBRARY FORMATION Final Rejection Agilent Technologies, Inc.
18271727 METHODS AND COMPOSITIONS FOR MOLECULAR TRACKING IN INDIVIDUAL CELLS IN VIVO Non-Final OA The Regents of the University of Colorado, a body corporate
17441741 HIGH-THROUGHPUT SINGLE-CELL LIBRARIES AND METHODS OF MAKING AND OF USING Non-Final OA University of Washington
17561626 INCREASING DYNAMIC RANGE FOR IDENTIFYING MULTIPLE EPITOPES IN CELLS Final Rejection Roche Sequencing Solutions, Inc.
17753592 CRISPR-MEDIATED CAPTURE OF NUCLEIC ACIDS Non-Final OA OREGON HEALTH & SCIENCE UNIVERSITY
18885481 METHODS OF PREPARING LOOP FORK LIBRARIES Final Rejection Illumina, Inc.
17518135 SYSTEMS AND METHODS FOR MAKING SEQUENCING LIBRARIES Final Rejection ILLUMINA, INC.
17570073 CONVERSION OF STRAND DISPLACEMENT APTAMERS INTO MOLECULAR BEACONS Non-Final OA GENESEE VALLEY INNOVATIONS, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month